Pathway Medical lands generous $40M to treat arterial disease
Pathway Medical Technologies, maker of a non-invasive catheter capable of removing all kinds of artery blockages and build-up, says it just scored $40 million in a fourth round of funding — a pretty high figure for a life science device manufacturer these days. Only about 11 percent of these companies have raised more than $25 million in the last two years. The Kirkland, Wash. company says it will use the money to grow its sales team and manufacturing operations.
Its lead product, the Pathway Jetstream G2, earned Food and Drug Administration approval this year, and is an enhanced version of its first catheter launched in September. It’s used by 100 medical centers across the U.S. and has already successfully treated 600 patients suffering from arterial disease, the company claims.
The round came from Forbion Capital Partners, HLM Venture Partners,Latterell Venture Partners, Oxford Bioscience Partners, Giza Venture Capital and a handful of private investors.
Next Story: See who’s talking about you, not just at you on Twitter
Previous Story: Game industry executives react to OnLive video games on demand announcement
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.